SomnoMed
SomnoMed Limited is an ASX-listed Australian medical device company that designs, manufactures, and distributes the SomnoDent family of custom-fitted mandibular advancement devices, serving OSA patients worldwide via dental sleep medicine professionals across 28 countries.
- Company typePublic
- Founded2004
- HeadquartersNorth Sydney, Australia
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What SomnoMed does
SomnoMed Limited (ASX: SOM), founded in 2004 and headquartered in North Sydney, Australia, is a medical device company that develops, manufactures, and commercialises oral appliances for the treatment of obstructive sleep apnea (OSA) and related sleep-disordered breathing. The company states it is the world's largest supplier of oral sleep apnea devices, having delivered over one million oral appliances to patients across 28 countries and six continents, with 501–1,000 employees and revenue of AUD 60.7 million reported for H1 FY26 (13% YoY growth).
The product portfolio centres on the SomnoDent family of custom-fitted mandibular advancement devices (MADs): SomnoDent Avant (flagship, CAD/CAM-milled from single-piece pre-cured PMMA), SomnoDent Flex, SomnoDent Fusion, SomnoDent Classic, Herbst Advance, and Herbst Advance Elite (Medicare-approved in the US). All devices incorporate the proprietary b-flex Comfort Liner for retention and comfort and are manufactured in ISO 13485-certified facilities. In 2024–2026 the company secured FDA 510(k) clearance for Rest Assure, an oral appliance with built-in objective compliance monitoring, with a commercial soft launch anticipated in FY27 to accelerate US market entry.
SomnoMed operates a B2B2C distribution model: sleep physicians diagnose OSA and refer patients to certified dental sleep medicine professionals, who fit and titrate the devices. The company does not sell direct to patients. Supporting revenue streams include SomTabs cleaning tablets, the SomMorning Repositioner, SomnoBrux, and the SomGauge diagnostic tool, distributed via the SomAccount B2B portal active in the US, Australia, ANZ and several European markets. SomnoMed Academy provides training and certification to grow the provider network, and the FY26 full-year revenue guidance was reaffirmed at AUD 119–126M with EBITDA of AUD 10–12M (H1 FY26 EBITDA AUD 7.8M, up 35% YoY with 200bps margin expansion).
SomnoMed firmographics
Firmographics- Name
- SomnoMed
- Legal name
- SomnoMed Limited
- Website
- https://somnomed.com
- Company type
- Public
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- SomnoMed Limited is an ASX-listed Australian medical device company that designs, manufactures, and distributes the SomnoDent family of custom-fitted mandibular advancement devices, serving OSA patients worldwide via dental sleep medicine professionals across 28 countries.
- Ownership category
- akta.pro rank
SomnoMed industry classification
Industry- Product category
- Sleep Apnea Treatment Devices (Medical Devices for Sleep Disorders)
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Dental Equipment and Supplies Manufacturing (339114)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Dental Equipment & Supplies (3843)
- akta.pro industry
- Sleep & Airway Orthodontics (OSA Appliances/Expansion)Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV)Sleep Surgery & Snoring (ENT)
Keywords
Where SomnoMed is headquartered
LocationHeadquarters
- HQ city
- North Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices18 records
Markets served
SomnoMed business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Oral Appliance Sales: Sale of custom-fitted mandibular advancement devices (MADs) for obstructive sleep apnea treatment. Devices are prescribed by sleep physicians and fitted by dental sleep medicine professionals. Revenue generated from dental practices purchasing devices for patient fitting.
- SomTabs and Accessories: Ongoing sales of cleaning tablets, elastic bands, travel cases, and brushes for device maintenance. Available through e-commerce portals in multiple countries.
- Professional Services and Training: SomnoMed Academy provides training and certification programs for dental professionals looking to establish or expand dental sleep medicine practices.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Custom oral appliance pricing varies by device type and insurance coverage |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
SomnoMed product offering
Product offeringCore offering
SomnoMed develops, manufactures, and sells custom-fitted mandibular advancement devices (MADs) under the SomnoDent brand for the treatment of obstructive sleep apnea (OSA) and snoring. The company distributes these medical devices through a global network of certified dental sleep medicine professionals and sleep physicians across 28 countries, with all devices manufactured to ISO 13485 medical device quality standards. The portfolio includes the flagship SomnoDent Avant (CAD/CAM-milled), SomnoDent Classic, SomnoDent Flex, SomnoDent Fusion, Herbst Advance Elite (Medicare-approved), Herbst Advance, and the next-generation Rest Assure with FDA-cleared built-in compliance monitoring.
Product overview
SomnoMed is the world's largest supplier of oral sleep apnea devices, offering the SomnoDent family of mandibular advancement devices for treating obstructive sleep apnea (OSA). The product portfolio centers on the SomnoDent brand, which includes six distinct oral appliance models: SomnoDent Avant (flagship CAD/CAM-milled device), SomnoDent Fusion, SomnoDent Flex, SomnoDent Classic, Herbst Advance Elite (Medicare-approved), and Herbst Advance. All SomnoDent devices feature the proprietary b-flex Comfort Liner technology for enhanced comfort and retention. Supporting accessories include SomTabs cleaning tablets, SomMorning Repositioner, SomnoBrux, and SomGauge diagnostic tool. The latest innovation is Rest Assure, FDA-cleared as the industry's first oral appliance with built-in compliance monitoring. Products are distributed through dental sleep medicine professionals across 28 countries and are manufactured in ISO 13485-certified facilities.
Differentiator
Problem solved
Functional benefit
Brands
- SomnoDent: Family of oral devices for treating obstructive sleep apnea including SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, SomnoDent Fusion, Herbst Advance, and Herbst Advance Elite
- b-flex Comfort Liner
- SomTabs
- SomMorning Repositioner
- SomnoBrux
- SomGauge
- SomAccount
- Rest Assure
- First Time Fit
- Effectiveness Equation
- SomnoMed Academy
Products and services
- SomnoDent Avant
- SomnoDent Flex
- SomnoDent Fusion
- SomnoDent Classic
- SomnoDent Herbst Advance Elite
- Herbst Advance
- Rest Assure
- SomTabs
- SomMorning Repositioner
- SomnoBrux
- SomGauge
- SomnoMed Academy Training and Certification
Quantifiable outcome
- 91% of patients experience improved sleep quality with SomnoDent Avant
- +4 more outcomes
Companies that use SomnoMed
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
SomnoMed technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
SomnoMed partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and foundational.
- Sleep Physicians (Global Network)coreSleep physicians diagnose OSA and refer patients to certified dental sleep medicine providers for device fitting. This network of medical professionals is essential to SomnoMed's go-to-market strategy, as oral appliances require medical prescription. The company actively supports physician-dentist collaboration through its Medical Initiative program.
- Dental Sleep Medicine Practitioners (Global Network)coreOver 1 million patients treated through partnership with dental professionals trained in sleep medicine. These providers evaluate patients, take impressions/scans, fit devices, and provide ongoing titration. The company supports this network through SomnoMed Academy training and the SomAccount ordering portal.
- Dr. Richard Palmisano (Original Inventor)foundationalSomnoMed's original oral appliance technology was invented by Dr. Richard Palmisano. The company manufactures devices based on this original invention, which established the foundation for the company's product portfolio and market position.
Scale indicators12 records
Recent moves5 records
Expansion highlights5 records
SomnoMed competitors and assessment
Company assessmentBroad incumbents
- Philips Respironics: Philips Respironics is a major incumbent in sleep and respiratory care with a portfolio spanning CPAP, BiPAP, and related monitoring. It defines the standard-of-care payer pathway that oral appliances compete against.
- BMC Medical: BMC Medical manufactures CPAP, BiPAP, and related respiratory devices and is a global incumbent in sleep-disordered-breathing therapy. It competes broadly in the OSA treatment space that SomnoMed serves with oral appliances.
- Itamar Medical (ZOLL Itamar): Itamar Medical (now part of ZOLL) provides sleep diagnostic and monitoring solutions used by sleep physicians who also prescribe SomnoMed's devices. It is an adjacent incumbent in the OSA diagnosis-and-monitoring pathway.
- ResMed: ResMed is the global leader in CPAP and broader sleep-disordered-breathing therapy. While its core offering is CPAP, it is the dominant incumbent in the OSA market that SomnoMed's oral appliances position against as an alternative.
Emerging players
- Vivos Therapeutics: Vivos Therapeutics develops oral appliances for OSA and sleep-disordered breathing, with a growing emphasis on the dentist-administered Vivos System. It is an emerging player overlapping with SomnoMed's dental channel go-to-market.
Direct peers
- Airway Management: Airway Management manufactures the TAP and myTAP custom oral appliances for OSA and snoring. It is a long-standing direct peer selling mandibular advancement devices through dentists and sleep physicians.
- Oventus Medical: Oventus Medical (now part of SomnoMed-adjacent competitor landscape) developed the O2Vent oral appliances for OSA from Australia. It is a regional peer directly comparable as an Australasian oral appliance manufacturer targeting the same patient population.
- ProSomnus Sleep Technologies: ProSomnus manufactures precision-engineered, CAD/CAM-milled mandibular advancement devices for OSA. It is the closest direct competitor to SomnoMed's SomnoDent Avant line, targeting the same dental sleep medicine channel with similar premium positioning.
- Panthera Dental: Panthera Dental designs and manufactures custom CAD/CAM sleep apnea oral appliances (Panthera D-SAD Classic and Classic Pro). It competes directly with SomnoMed across multiple geographies including North America and Europe.
- Whole You (Resonas / Mitsui Chemicals): Whole You (formerly Resonas, owned by Mitsui Chemicals) provides custom oral appliances for OSA and is a direct competitor in the US dental channel with similar CAD/CAM-style device offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
SomnoMed social profiles
Digital presenceSomnoMed compliance and trust
Trust signalCompliance1 record
SomnoMed financial estimates
Financial estimateRevenue estimate
Valuation estimate
SomnoMed leadership team
Management profileNumber of profiles
Profiles2 records
SomnoMed funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SomnoMed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SomnoMed
What does SomnoMed do?
SomnoMed develops, manufactures, and sells custom-fitted mandibular advancement devices (MADs) under the SomnoDent brand for the treatment of obstructive sleep apnea (OSA) and snoring. The company distributes these medical devices through a global network of certified dental sleep medicine professionals and sleep physicians across 28 countries, with all devices manufactured to ISO 13485 medical device quality standards. The portfolio includes the flagship SomnoDent Avant (CAD/CAM-milled), SomnoDent Classic, SomnoDent Flex, SomnoDent Fusion, Herbst Advance Elite (Medicare-approved), Herbst Advance, and the next-generation Rest Assure with FDA-cleared built-in compliance monitoring.
Is SomnoMed a public or private company?
SomnoMed is a public company. It is classified as public and is currently operating.
When was SomnoMed founded?
SomnoMed was founded in 2004. It employs 501 to 1,000 people.
Where is SomnoMed based?
SomnoMed is headquartered in North Sydney, Australia, in the Oceania region.
How does SomnoMed make money?
Three revenue lines are on record. Oral Appliance Sales are the primary driver. The others are somTabs and Accessories and professional Services and Training.
Who are SomnoMed's main competitors?
Broad incumbents on record are Philips Respironics, BMC Medical, Itamar Medical (ZOLL Itamar) and ResMed. Vivos Therapeutics is listed as an emerging player. Direct peers are Airway Management, Oventus Medical, ProSomnus Sleep Technologies, Panthera Dental and Whole You (Resonas / Mitsui Chemicals).
Does SomnoMed have an API?
No public API is recorded for SomnoMed.
What industry is SomnoMed in?
SomnoMed's product category is Sleep Apnea Treatment Devices (Medical Devices for Sleep Disorders). Its primary akta.pro industry code is HLABABAI, Sleep & Airway Orthodontics (OSA Appliances/Expansion), with a secondary code of HLAHAGAA, Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV). Its NAICS code is 339113 and its SIC code is 3842.